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INTRODUCTION
India is experiencing an unprecedented rise in the incidence of breast cancer as all other
countries. Since there is no preventive measures for breast cancer, it is necessary to detect
it early and treat adequately to achieve a longer survival. Fine needle aspiration cytology
is a widely accepted diagnostic tool. But it has limitations in terms of sensitivity,
specificity and diagnostic accuracy. The noble quality of FNAC depends on the
proficiency of the aspirator, and its analysis is determined by the experience of the
pathologist.
Many times FNAC diagnosis is suspicious but not confirmatory. And also risk of over
treatment that is mastectomy could be done on the ground of false positive diagnosis.
Hence the need for intra-operative confirmation of the condition of the tumour to make a
therapeutic decision, led to the development frozen section technique.
But it requires specialized equipment, freezing of tissues and serial sectioning. Imprint
smear cytology is the substitute to frozen section. And it is taken from the tumours and
stained with eosin and haematoxyllin. It does not require specialized equipment. Imprint
cytology has become important tool for diagnosis of various lesions as it is rapid,
inexpensive and less time consuming.
Therefore, this work is done to assess the accuracy of intra operative imprint smear.
REVIEW
OF
LITERATURE
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REVIEW OF LITERATURE
“Black bile, karkinos, Nun’s disease and God’s punishment” are various names for breast
cancer. In India it is the first most common cancer in urban women and second most
common in rural women after cancer cervix. The overall five yearr survival rate has been
increasing and it is 89% but in India it is 59%.
Women under age 40 are much less likely to develop breast cancer. But the five-year
relative survival rate is lower than it is for women over 40. Younger women are more
likely to be diagnosed with aggressive types of breast cancer that tend to spread faster
and are more likely to recur.
With the goal of diagnosing the disease at an earlier stage various diagnostic methods
have been developed.
Owing to early diagnosis and improved treatment modalities, the mortality due to breast
cancer has significantly reduced.
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SURGICAL ANATOMY
Breast or mammary gland is a modified sweat gland. It lies in the superficial fascia.
The mature female breast extends from 2nd to 6th rib vertically and from lateral border of
sternum to the anterior axillary fold transversely. A thin layer of breast tissue extends
above the clavicle and to the 7th rib below .The aim of mastectomy is to remove whole of
the breast tissue and hence this has to be remembered.
The axillary tail of Spence extends from the lateral border of breast piercing the deep
fascia into anterior axillary fold and if well-developed it is mistaken for lymph node mass
or lipoma.
Cooper’s suspensory ligaments are fibrous strands of connective tissue that traverse the
breast from the pectoral fascia and insert into the dermis perpendicularly to provide
structural support. They are responsible for dimpling of skin overlying  atumour.
Axillary
tail
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The posterior surface of breast lies over pectoral fascia covering pectoralis major,serratus
anterior and upper portion of rectus sheath. The loose areolar tissue (retromammary
space) lies between breast and pectoralis fascia.
The breast parenchyma is made up of glandular tissues. The gland contains 15 to 20 lobes
composed of numerous lobules which vary from 10 to 100 .each lobe is drained by
lactiferous ducts which converge towards the nipple. Near its termination it is provided
with a terminal dilatation called lactiferous sinus or ampulla,which is a reservoir for milk
or any discharge.Both the alveoli and the ducts are lined bymyoepithelial cells which
facilitates milk secretion.
The stroma forms the supporting tissue of the breast,it is partly fibrous and partly fatty.
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The nipple is a conical projection just below thecentre of the breast. It is pierced by
lactiferous ducts at its apex. It contains both longitudinal and circular muscle fibres that
keeps the nipple erect and stiff. It has rich sensory nerve endings.
The areola is a circularpigmented area at the base of the nipple. It is rich in sweat and
sebaceous glands, which becomes enlarged during pregnancy and lactation to form
Montgomery tubercles,for lubrication.
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BLOOD SUPPLY:
It is extremely vascular and is supplied by
· Perforating branches of Internal thoracic artery,
· Lateral br of posterior intercostal arteries,
· Lateral thoracic ,superior thoracic and  pectoral br of acromiothoracic-branches of
axillary artery .
The posterior surface breast tissue is relatively avascular.
7 | P a g e
VENOUS DRAINAGE:
The veins follow the arteries.
Veins converge around the nipple to form anastomotic circle
They form:
Superficial veins: they drain into internal thoracic vein and
Deep veins:they drain into internal thoracic vein, axillary vein, and posterior intercostal
vein.
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NERVE SUPPLY:
4th to 6thintercostals nerves through anterior and lateral cutaneous branches
Milk secretion is by the action of prolactin, not by nerves.
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LYMPHATICS:
Carcinoma of breast predominantly spread through lymphatics to the regional lymph
nodes. About >75% of lymph from the breast drains into the axillary nodes and they are;
AXILLARY:
· Anterior or pectoral group- along lateral thoracic vessels
· Posterior  or scapulargroup-along subscapular vessels
· Lateral or deltoid group-along axillary vein
· Central group-embedded in the fat of axilla
· Apical or subclavicular group-superior to the pectoralis minor tendon,receives
from all other groups of axillary nodes. Finally drains into supraclavicular nodes
· Interpectoral or rotter’s node - between pectoralis major and minor muscles
Internal mammary or parasternal nodesalong internal mammary vessels (10%)
Others (5%):
· Supraclavicular
· Cephalic / deltopectoral
· Posterior intercostals
· Subdiaphragmatic
· Subperitoneal
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RISK FACTORS FOR BREAST CANCER
NON MODIFIABLE FACTORS:
· Female
· Increasing age
· Early menarche (<12 yrs)
· Late menopause (>55 yrs)
· Nulliparous women
· Family h/o breast cancer
· Genetic (BRCA1 and BRCA2 mutations)
· Previous h/o breast cancer
· Race, ethnics (white women)
· H/o radiation exposure
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MODIFIABLE RISK FACTORS:
· Lack of breast feeding
· Age at first live birth (first pregnancy > 30 yrs)
· Parity
· Obese women
· H/o alcohol consumption
· Tobacco intake
· Hormone replacement therapy
· Night works
· Decreased physical activity
· HISTOLOGIC FACTORS:
· Proliferative breast disease
· Atypical ductal hyperplasia
· Atypical lobular hyperplasia
· Lobular carcinoma in situ
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BENIGN BREAST DISEASES
Benign lesions are much more common than malignant and about 16% of women of age
40-69 will seek physician regarding breast complaints such as pain, lumpiness or lump.
The diagnosis of a benign breast disease is established withthe use of mammography,
ultrasound, and MRI of the breast and biopsieswithout surgery in the majority of patients.
Since majority of benign lesions of breast are not allied with a risk for subsequent breast
cancer, it is necessary to avoid surgical procedures. It is essential to recognize benign
lesions, and also to differentiate in situ and invasive breast cancer. So that we can assess
the patient’s possibility of developing breast cancer and also provide the mostsuitable
treatment.
The term “benign breast diseases” encompasses a heterogeneous group of lesions that
may present with the wide range of symptoms. It may be detected as incidental
mammographic findings. The incidence of benign breast disease begins to increase
during the 2nddecade of life and peaks in the 3rdand 5thdecades, as opposed to the
malignant lesions, for which the incidence continues to increase after menopause,but at a
less rapid pace.
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INFLAMMATORY DISEASES OF BREAST
ACUTE MASTITIS:
Acute mastitis(4) usually occurs in lactating mothers,particularly the first 3 months of
postpartum.  It is also known as puerperal or lactational mastitis.Most common organism
is Staph.aureus. It causes cellulitis of the connective tissue of the breast parenchyma.If
left untreated it results in abscess formation and septicemia.
Risk factors are:
· Improper feeding technique
· Cracked or sore  nipple and
Early diagnosis and early management at the stage of cellulitis is necessary to
prevent abscess formation.  Breast support, local heat, emptying the breast with
frequent feeding andexpressing and appropriate antibioticsand analgesics seems to
be the most appropriate treatment.
If antibiotic is given in the presence of abscess it results in ‘antibioma’ formation.
If infection does not resolve, incision and drainage is usually
recommended.Nevertheless, ultrasonogram guided needle aspiration and
appropriate antibiotics are better options with excellent cosmetic outcomes.
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GRANULOMATOUS MASTITIS(4)
Itmaybe due toinfection, foreign body, or systemic autoimmune disorders. Diagnosis can
be made only after microbiological, immunological and histopathological evaluation.
granulomatous mastitis is caused by different type of organisms . The most common
autoimmune disease are Wegener’s granulomatosis and Sarcoidosis.
TUBERCULOUSMASTITIS
Tuberculosis of the breast is a very raremanifestation  of TB and often associated with
pulmonary tuberculosis /or TB adenitis. However, tuberculous mastitis cannot be
diagnosed easily,by clinical and radiological features. It may resemble with either
carcinoma of breast or pyogenic abscess of breast. Usually presents with multiple chronic
abscesses and fistula.Final diagnosis of the disease is based on bacteriological and
histopathological examination.Appropriate anti-tuberculous drug therapy is the treatment
of choice.
IDIOPATHIC GRANULOMATOUS MASTITIS
They are granulomatous lesion,for which causeis unkown. The treatment for idiopathic
granulomatous mastitis is complete excision of the lesion, followed  bysteroid therapy. In
50% of cases even when treated appropriately, persistence, recurrence and complications
occurs.The complications are abscess formation, fistulae and chronic suppurative lesions.
So long term follow-up is necessary.
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FOREIGN BODY REACTIONS
The silicone and paraffin are foreign materialsused for breast reconstructive procedures
after mastectomy and also for augmentation. It may cause a foreign body reactions,
which is of granulomatous type of reactions in the breast. ‘siliconomas’ are granulomas
that occurs afterextracapsular rupture of silicon implant or injection of silicone into the
breast. Fibrosis and contractions may develop and forms firm nodules that may be
tender.
ZUSKA’S DISEASE: (4)
It is a recurring subareolar abscess that is due to unusual bacterial infection of the breast.
It is a triad of:
· cutaneous fistula
· past-like discharge from the nipple and
· H/o multiple recurrentabscesses of the breast.
It is due to squamous metaplasia of the lactiferous ducts, which are obstructed by keratin
plugs, causing dilatation of the proximal duct. It then becomes infected and results in
abscess formation underneath the nipple and areola. The abscess typically drains at the
margin of the areola. Abscess is drainedinitially and after inflammation subsides,
complete removal of the duct that is involved and sinus tract excision is done.
Butrecurrence of abscess occurs when it involves another duct.
17 | P a g e
ABERRATION OF NORMAL DEVELOPMENT AND INVOLUTION
This term was described by the Cardiff breast clinic.  The principles are:
· Benign breast disorder or disease is due to normal physiological process of
reproduction and due to involution
· There is spectrum of conditions that ranges from normal to disease process
· The classification includes pathogenesis and varying degrees of abnormalities
PATHOLOGY:
It includes four features that varies in degree and extent:
· Cyst formation
· Fibrosis
· Hyperplasia
· Papillomatosis
CLINICAL FEATURES:
Lump – fibroadenoma or cyst
Lumpiness in both breast, may be cyclical and is associated with tenderness.
Non cyclicalmastalgia – in perimenopausal and post menopausalwomen ,
associated with periductal mastitis or ANDI.
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ANDI CLASSIFICATION OF BENIGN BREAST DISORDERS
Normal Disorder Disease
Early reproductive
Years (15-25)
Lobular
development
fibroadenoma Giant fibroadenoma
Stromal
development
Adolescent
hypertrophy
Gigantomastia
Nipple eversion Nipple inversion Subareolar abscess
mammary duct fistula
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Later reproductive
years (25-40)
Normal
Cyclical changes of
menstruation
Disorder
Cyclical mastalgia
Disease
Incapacitating
mastalgia
nodularity
Epithelial
hyperplasia of
pregnancy
Bloody nipple
discharge
Involution age(35-
55)
Lobular involution macro cyst
Sclerosing lesion
Duct involution
dilatation Duct ectasia Periductal mastitis
sclerosis Nipple retraction
Epithelial turnover Epithelial
hyperplasia
Epithelial hyperplasia
with atypia
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NON PROLIFERATIVE DISORDERS
They account for 70 % of benign disorders and they do not carry any risk for the
development of cancer. It includes:
1) BREAST CYSTS:
Macrocysts are involutionaldisordesand are often multiple.
They are fluid filled, epithelial lined cystic cavities present within breast parenchyma.
Sizes vary from microscopic to large palpable massesand may contain 20 to 30 ml fluid.
The fluid can be straw color, dark green or opaque and also contains debris.It can be
aspirated ,no further treatment is required. But 50 % of cysts are multiple and recurrent.It
is seen in women > 35 yrs of age and it is influenced by ovarian hormones.
The incidence of intracystic carcinoma is 0.1 %. If there is recurrence after aspiration for
2 times, solid component has to be evaluated by cystopneumography and the aspirate is
sent for cytological analysis. The core biopsy or FNAC is done to rule out solid
component, cystadenocarcinoma which is common in elderly women.Indications for
surgical removal are recurrence after multiple aspirations and dependingupon the needle
biopsy report.
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2) DUCT ECTASIA:
 It is characterized by palpable dilated subareolar ducts which is filled with green or
brown secretions,that may present with nipple discharge.This may lead to periductal
mastitisor even abscess and fistula. Sometimes presents with indurated mass behind the
nipple or slit like nipple retraction mimicking carcinoma. Another theory suggests that
periductal inflammation is responsible for ductal dilatation. It can be treated with
antibiotics, however excision of all major ducts (Hadfield’s operation) is the only option
for complete cure.
3) FIBROADENOMAS
It is the 2nd most common tumourof the breast after carcinoma and it is a benign tumour
made of epithelial and stromalelements. It is the most common tumour inwomen < 30 yrs
of age. They present as a freely mobile, palpable firm mass, referred as breast mouse.
They are well encapsulated with the smooth or lobulated surface. The size more than 5cm
is termed as Giant fibroadenoma. Development of cancer in fibroadenoma is very rare, of
which 50 % are LCIS, 35 % of neoplasia are infiltrating 15 % are intra ductal carcinoma.
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 GIANT FIBROADENOMA
4) HAMARTOMAS AND ADENOMAS:
Adenomas are composed of benign epithelium packed closely to form a sheet of glands
with scanty stromal elements, which distinguishes it from fibroadenoma. They may
increase in size during lactation and pregnancy. They are of two types: tubular and
lactating adenomas. The tubular variety is seen in young non pregnant women. Lactating
adenomas are found during pregnancy and postpartum period.
Hamartomas are discrete,firm well circumscribed tumours measuring 2 to 4 cm in
diameter. They contain tightly packed lobules and prominent extralobular ducts.
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PROLIFERATIVE BREAST DISORDERS WITHOUT ATYPIA:
1) PAPILLOMASAND PAPILLOMATOSIS:
Papillomas are true polyps of breast duct which are lined by epithelium and are located
close to the areola at a peripheral location. It can be solitary or multiple. It is
pinkish,friable lesion,attached by stalk to the wall of the involved duct.They are often
accompanied by bloody nipple discharge.They present as palpable mass beneath the
areola very rarely. The size varies from < 1 cm to 4 or 5cm. It is excised through
circumareolar incision. They rarely undergo malignant transformation.
Papillomatosis is referred as epithelial hyperplasia that fills the individual ducts
resembling polyp without fibrovascular tissue, associated with fibrocystic changes.It
commonly occurs in younger women
2) SCLEROSING ADENOSIS:
It refers to increase in number of terminal aciniassociated with proliferation of stromal
tissues. It is indistinguishable both grossly and histologically from carcinoma. The
mammogram may show deposition of  calcium in a pattern similar to microcalcification
found in intraductal carcinoma.
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3) RADIAL SCAR:
It is acomplex sclerosing lesion which contains microcysts, epithelial
hyperplasia,adenosis and central sclerosis. It mimics carcinoma mammographically with
irregular spiculations in the surrounding stroma. In mammogram larger lesions appear as
spiculated mass with distortion of architecture and even produce skin dimpling clinically.
They have moderate risk to develop into carcinoma. Hence it is necessary to rule out
carcinoma by excision biopsy.
4) DUCTAL HYPERPLASIA:
Mild: Presence of 3 or 4 layers of cells over basement membrane.
Moderate: presence of 5or more layers above the basement membrane.
Florid: epithelial hyperplasia occupying atleast 70 % of minor duct lumen. It carries 1.5
to 2 fold increased risk for cancer.
The most important features of epithelial hyperplasia are an mixture of different cell
types :epithelial cells, myoepithelial cells and metaplastic apocrine cells , and variation in
the appearances of epithelial cells and their nuclei.
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(A): Usual ductal hyperplasia: proliferating epithelial cells that partially occlude the
lumen.
(B):Florid epithelial hyperplasia. Proliferating clusters of hyperplastic cells with
overlapped and unevenly distributed nuclei. It obliterates and distends the duct lumens.
(C): Atypical ductal hyperplasia: It is characterized by monotonous proliferation of
regularly arranged cells(cribriform pattern). Although it displays features of low-grade
intraductal carcinoma, this lesion is interpreted as atypical ductal hyperplasia ,as it is seen
only in a single and small focus.
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ATYPICAL PROLIFERATIVE DISEASES:
Atypical ductal hyperplasia (ADH):
It was described based on exclusion criteria, i.e. the presence of some but not all of the
features of DCIS and also lack usual features of epithelial hyperplasia. It mimics low
grade DCIS. Lesions less than 2mm in maximum dimension, involving few or a portion
of ducts is described as ADH and a larger one as DCIS. It is seen in 4% of symptomatic
benign biopsies and 31% of biopsies performed for microcalcifications.Premenopausal
women ADH have a higher risk invasive cancer.It requires excision biopsy of the lesion
for confirmation,as core needle biopsy cannot establish the diagnosis
Atypical lobular hyperplasia(ALH)
The features of lobular type epithelial proliferations are very similar, and the only
difference between ALH and LCIS is the extent and degree of epithelial proliferation, and
ALH is characterized by minimal distension of lobular units compared to LCIS made of
monomorphic cells with fully distended aciniwhile maintaining the overall lobular
architecture.Both the lesions are regarded and managed as a risk factor rather than
precursors for invasive cancer.
Both ADH and ALH have4 fold increased risk for cancer development.
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CANCER RISK ASSOCIATED WITH BENIGN BREAST DISORDERS AND IN
SITU CARCINOMA OF THE BREAST
Abnormality Relative risk
Non proliferative lesions of the breast No increased risk
Sclerosingadenosis No increased risk
Intraductal papilloma No increased risk
Florid hyperplasia 1.5 to 2 fold
Atypical lobular hyperplasia 4 –fold,
Atypical ductal hyperplasia 4 –fold, 10 fold (first degree relative + )
Ductal involvement by cells of atypical
ductal hyperplasia
7 -fold
Lobular carcinoma in situ 10 -fold
Ductal carcinoma in situ 10 fold
FAT NECROSIS:
It presents with palpable mass clinically mimicking carcinoma and also produces density
which contains calcium on mammogram. It has no malignant potential. It occurs
following a surgical procedure,or trauma or radiation treatment.
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PATHOLOGY OF BREAST CANCER
The breast cancer arises from the ductal epithelium anywhere from the lactiferous duct to
the terminal lobule. With the advent of breast cancer screening, in situ lesions are the
more common finding compared to the invasive cancer.
There are three grades of differentiation of tumour:
Well differentiated,moderately differentiated or poorly differentiated.
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BLOOM RICHARDSON GRADING OF CARCINOMA BREAST
TUBULE FORMATION:
· Score 1: >75% of tumor area forming tubules
· Score 2: 10% to 75% of tumor area forming tubules
· Score 3: <10% of tumor area forming tubules
NUCLEAR PLEOMORPHISM:
· Score 1: Nuclei uniform in shape, relatively small size in comparison with normal
breast epithelial cells, uniform nuclear chromatin.
· Score 2: nuclei are intermediate size, normal with open vesicular nuclei, visible
pleomorphic nucleoli
· Score 3: Vesicularrelativelylarge nuclei, with prominent nucleoli, marked
variation in size and shape, occasionally with bizarre forms.
MITOTIC COUNT:
· Score 1: less than or equal to 10 mitoses per 10 high power fields
· Score 2: less than 20 and more than 10 mitoses per 10 high power fields
· Score 3:  greater than 20 mitoses per 10 high power fields
OVERALL GRADE:
· Grade 1: scores of 3, 4, or 5 ( LOW)
· Grade 2: scores of 6 or 7 (INTERMEDIATE)
· Grade 3: scores of 8 or 9 (HIGH)
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CLASSIFICATION OF PRIMARY BREAST CANCER(2)
Non invasive epithelial tumours:
· Lobular carcinoma in situ
· uctal carcinoma in situ
Invasive epithelial tumours:
· Invasive ductal carcinoma
1. Not otherwise specified(50- 70%)
2. Special types:
a. Tubular
b. Mucinous
c. Medullary
d. Colloid
e. Invasive cribriform
f. Invasive papillary
g. Adenoid cystic
h. Metaplastic
· Invasive lobular carcinoma (10%)
· Mixed Epithelial and connective tumours:
a. Phylloides
b. Angiosarcoma
c. Carcinosarcoma
d. Adenocarcinoma
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CARCINOMA IN SITU:
Broder’s described in situ lesions are those in which tumour cells do not invade into the
surrounding stroma and are confined to the ductal and alveolar boundaries.With the aid of
screening mammography,increased incidence of in situ lesions was demonstrated.
LCIS:
It is developed only in females and characterized by conformity to normal duct lobules
and contains distended and filled acini.Multicentricity occurs in 60 -90 % of women and
bilateralityoccurs in 50 -70 % of women with LCIS.LCIS is a marker for increased risk of
invasive breast cancer.The patients are counseled for screening procedures,
chemoprevention and prophylactic bilateral mastectomy.
DCIS:
It is characterized by malignant epithelial cells proliferation within the breast
parenchymal structures with no evidence of the basement membrane invasion.
Incidence is 5- 10 %, although predominantly occurs in female breast,it accounts for 5%
of male breast cancers and  is also referred as intraductal carcinoma. There are four
morphological categories: papillar, cribriform, solid ,andcomedo.The solid and comedo
types of DCIS are higher grade lesions.Its progression to invasive cancer is high(5 fold).It
is an anatomic precursor of invasive ductal carcinoma. Microcalcificationsare common
features of DCIS.
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INVASIVE BREAST CARCINOMA:
They are characterized by lack of architecture, variable amount of stromal infiltration and
formation of sheets of cells.About 80 % of invasive breast carcinomas are NOS type of
invasive ductal carcinoma.
Paget’s disease of the nipple presents with eczematous eruption of nipple, mass may or
may not be present. Paget’s cells/ malignant cells extend from the DCIS lesion along the
lactiferous duct to the nipple skin without involving the basement membrane.
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Invasive ductal carcinoma is also known as infiltrating ductal carcinoma.When it does
not have any special featureit is referred as NST type .It presents with firm,solitary mass
in perimenopausal and post menopausal women.60 % of cases presents with axillary
lymph node metastasis.
A) Invasive ductal carcinoma                         B) Medullary carcinoma
Medullary carcinoma accounts for 4% of invasive breast cancers.Bilaterality is seen in
20% of cases and it is a frequent type of BRCA1 breast cancer.These patients have a
better survival rate.It is characterized by peculiar invasive cells with increased mitoses
and high grade nuclear features.
Medullary variants are high grade, estrogen and progesterone receptor negative and also
her2/neu negative. They are termed as triple negative tumours.
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Mucinous carcinoma , is a low grade cancer,accounting for 2% of invasive breast
cancers.90 % of mucinous tumours show hormone receptors and lymph node metastasis
occurs in33% of cases.Because of the presence of mucinous content,cancer cells
sometimes are not evident, hence require multiple sections for evaluation to diagnose the
tumour.
                                             Mucinous carcinoma
Papillary carcinoma presents in seventh decade and accounts for 2% of all invasive
cancers. They are characterised by papillae with fibrovascular core and multilayered
epithelium.
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Tubular carcinomas accounts for 2% of all invasive cancers. It is characterized by
infiltrating cells forming glands lined by row epithelium.
Invasive lobular carcinoma accounts for 10% of breast cancer and has features of small
lobular neoplastic cells arranged in a single file,giving an Indian file pattern. It is usually
multifocal,multicentricand bilateral. It is difficult to detect because of its insidious growth
pattern and subtle features in mammography. >90% of lobular cancers are Estrogen
receptor positive.
Metastasis occurs to areas such as peritoneum, retroperitoneum, leptomeninges, GIT,
ovaries and uterus
Indian file pattern
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OTHER TUMOURS OF BREAST
PHYLLOIDES TUMOUR:
They aretumours of mixed connective tissue and epithelium. They are demarcated from
the surrounding ductal elements of breast, which appears compressed and distorted by
swirls of fibroblastic growth. They have mixed gelatinous, solid and cystic substances.
This gives a classical leaf like appearance (phylloides).
They are classified as benign, borderline and malignant. Benign are tumour masses with
average size of 5 cm. They resemble fibroadenoma but the stroma is more cellular. They
are indistinguishable mammographicallyfrom fibroadenoma. Hence, Excision biopsy
followed by histopathology gives the final diagnosis.
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Excision is sufficient for benign tumour.
Borderline tumours are excised with 1cm margins to prevent local recurrence.
Malignant tumours are treated similar to any soft tissue sarcomas. Complete surgical
excision of the tumour along with the surrounding normal tissue is the option. When the
tumour is very large simple mastectomy can be done.
Metastasis occurs to lungs, bone, abdominal organs and mediastinum hematogeneously.
ANGIOSARCOMA
They are vascular tumours arising from the breast after radiation therapy. It is also seen
developed in the upper extremity of post radical mastectomy patients with lymphedema.
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TNM STAGING FOR BREAST CANCER
PRIMARY TUMOUR
Tx Primary tumour cannot be assessed
T0 No evidence of primary tumour
Tis DCIS,LCIS,Paget’s of nipple
T1 Tumour<2cm
T2 Tumour>2and <5cm
T3 Tumour>5cm
T4a
T4b
T4c
T4d
Tumour of any size with chest wall extension
Tumour of any size with skin involvement
Both T4a and T4b
Inflammatory carcinoma
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REGIONAL LYMPH NODES
Nx Regional lymph nodes cannot be assessed
N0 No regional lymph node metastasis
N1 Metastasis to mobile ipsilateral level1 and 2 axillary nodes
N2a
N2b
Metastasis to ipsilateral level 1 and 2 axillary lymph nodes , fixed to one another
Metastasis to ipsilateral internal mammary nodes in the absence of level 1 and 2
Axillary LN
N3a
N3b
N3c
Metastasis to ipsilateral infraclavicular LN with or without level 1 and 2 axillary
LN or ipsilateral internal mammary nodes
Metastasis to ipsilateral internal mammary and axillary lymph nodes
Metastasis to  ipsilateral supraclavicular lymph nodes
DISTANT METASTASIS
Mx Distant metastasis cannot be assessed
M0 No distant metastasis
M1 Distant  metastasis
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TNM STAGE GROUPINGS
Stage 0 Tis N0 M0
Stage 1 T1 N0 M0
Stage 2a T0 N1 M0
T1 N1 M0
T2 N0 M0
Stage 2b T2 N1 M0
T3 N0 M0
Stage 3a T0 N2 M0
T1,T2 N2 M0
T3 N1 M0
T3 N2 M0
Stage 3b T4 N0 M0
T4 N1 M0
T4 N2 M0
Stage 3c Any T N3 M0
Stage 4 Any T Any N M1
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MANAGEMENT OF EARLY BREAST CANCER
Early breast cancer
Stage 1 and 2a & 2 b
Triple assessment
Clinical examination, imaging and
FNAC/core biopsy
Chest X ray, LFT , USG  abdomen,
determination of ER PR status
YES NOCandidates for BCS
BREAST CONSERVING THERAPY
· Wide excision
· Axillary dissection
· radiotherapy to breast
MODIFIED RADICAL MASTECTOMY
· Removal of entire breast,nipple and
areola
· Axillary dissection after retracting or
dividing the pectoralis minor
· Preserve pectoralis major
4 or more
positive nodes ER Positive
Tumour> 1cm
Age < 70yrs
Chemotherapy followed by
radiotherapy
Tamoxifen – 5yrs chemotherapy
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MANAGEMENT OF LOCALLY ADVANCED BREAST CARCINOMA
METASTATIC BREAST CARCINOMA:
Toilet mastectomy, hormone therapy, radiotherapy, chemotherapy and immunotherapy.
Locally advanced breast cancer
stage 3a and 3 b
Triple assessment
Clinical examination, imaging and
FNAC/core biopsy
Chest X ray, LFT , USG  abdomen,
determination of ER PR status, bone
scan
Complete/partial
response
Anterior chemotherapy (2-3 cycles)
and assess the response
Non responder /
progressive
BCS / MRM
Complete the
remaining cycles
Radiotherapy
operable
MRM
inoperable
Radiotherapy /
hormone therapy
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INVESTIGATIONS
Triple assessment:
· Clinical examination
· Imaging (mammogram/ultrasound)
· FNAC/core biopsy
MAMMOGRAPHY
Screening mammogramis done in asymptomatic patients with anaim of identifying breast
cancer at an early stage. Ithas a better prognosis and it requiresa less aggressive
treatment.American cancer society recommends annual screening for women > 40 years
of age. Soft tissue radiographs of low voltage and high amperage are taken.The dose is
0.5cGy.The sensitivity and specificity increases with age as breast tissue is replaced by
fat.
Diagnostic mammography is done to evaluate further in a patients with clinical findings
and in patients with abnormalities in screening mammogram.
The primary signs are:
· Spiculated mass
· Clustered pleomorphic microcalcification
The secondary signs are:
· Asymmetrical tissue density
· Skin thickening
· Focal distortion of tissues
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Digital mammography is superior to traditional mammography for younger women with
dense breast.
Non palpable mammographic abnormalities:
They are clustered microcalcifications and abnormal densities such as architectural
distortions and asymmetries that are not palpable clinically. The breast Imaging
Reporting and Data System is used to categorizing such lesions which are suspicious.
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BREAST IMAGING REPORTING AND DATA SYSTEM (BI –RADS)
CATEGORY DEFINITION REMARKS
0 Incomplete assessment Need additional imaging, or prior
mammogram for comparing.
1 negative Nothing to remark, recommend
annual screening
2 benign Annual screening
3 Probably benign Initial short  period  follow up
4 Suspicious abnormality (2-95%) Biopsy is required
5 Highly suggestive of malignancy
(95%)
Appropriate steps has to be taken
6 Known biopsy Proven malignancy
ULTRASONOGRAPHY:
It is useful in patients with dense breast and also to determine whether the swelling is
solid or cystic. Breast cancer has smooth margins with acoustic enhancement  and
irregular walls . The combination of ultrasonogram and mammogram increases the
diagnostic yield.It is not a good screening tool. It is used for guided FNAC and core
needle biopsy.
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MAGNETIC RESONANCE IMAGING:
· It is useful to identify the primary lesion in a axillary node positive patient with
absent mammographic evidence of the lesion in the breast
· To evaluate the extent of tumour in the dense breast
· To evaluate invasive lobular cancer and to detect contralateral tumour  in women
with unilateral lesion in mammography
· To distinguish scar from recurrent disease in patient who had undergone BCS
· Gold standard for imaging patients with breast implants
· Screening tool in high risk patients with BRCA mutation
· The sensitivity for invasive tumour is >90% and for DCIS <60%.
      MRI breast showing mass lesion before & after neoadjuvant chemotherapy
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FNAC:
Done with 22 or 23 G needle with an appropriate syringe and the needle is inserted
repeatedly with negative pressure in the syringe.The aspirate is properly smeared on a
slide for cytological examination. It is rapid and a least invasive technique. It is accurate
if the pathologists and operator are well experienced. False negatives occur due to errors
in sampling and it is difficult to distinguish in situ lesions from invasive tumours.
                   FNAC                                              CORE NEEDLE BIOPSY
CORE NEEDLE BIOPSY:
Procedure of choice for both palpable lesions and also for non palpable image detected
lesions.  After local anaesthetic infiltration 11gauge core biopsy needle is injected into
the lesion with vacuum assistance.<10% patients show inconclusive results. It is difficult
to distinguish between ADH and DCIS from invasive lesion in limited sample. The core
biopsy showing cellular fibroadenoma may require excision to rule out phylloidestumour.
This preoperative distinction of the tumourmay be clinically relevant for: (1) planning the
extent of the surgical operation especially if they are considering breast-conserving
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surgery; (2) considerations regarding neoadjuvant chemotherapy; and (3) the increased
risk of contralateral disease in the case of invasive lobular carcinoma warranting
contralateral radiological examination (MRI).
PITFALLS IN FNAC:
· There is difficulty In diagnosing low-grade malignancies and papillary
lesions
· It is based on subjective assessment hence there is  inevitable
difficulties in maintaining consistency and reproducibility in findings
· For large tumours (>4 cm) the accuracy rates are low.
· Calcified lesions are associated with a higher rate of insufficient
sampling.
· The diagnosis of tubular carcinoma and invasive lobular carcinoma is
very difficult.
· The diagnostic accuracy for papillary lesions is variable but low.
· Differential diagnosis between fibroadenoma and phylloidesby FNAC is
challenging due to shortage of universally accepted cytological criteria.
· Benign and normal lesions are often difficult to distinguish with FNAC.
· Pregnancy and lactation are associated with atypical breast changes they
are often misinterpreted.
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· Samples taken may not berepresentative of the lesion and there may be
contamination of samples by tissue adjacent to the target lesion
· Fat necrosis  is associated with reactive macrophages which resemble
malignant cells
· The incidence of inconclusive diagnoses in FNAC of breast tumour
ranges from 4% to18%.
· 45– 87% of aspirates of breast samples  classified as‘atypical’ and/or
‘suspicious’ are found to be malignant.
· The most common lesions in the ‘inconclusive’ diagnosis are
fibroadenomas and fibrocystic changes. Both lesions occasionally cause
cellular atypia that would necessitate histologic evaluation to rule out
the possibility of malignancy.
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FALSE POSITIVE occurs in:
§ Papillary lesion
§ Epithelial hyperplasia with nuclear atypia
§ Radial scar, complex sclerosing lesion
§ Fibroadenoma
§ Regenerative epithelial atypia
§ Skin adnexal tumours
FALSE NEGATIVE occurs in:
§ Tumour with central necrosis
§ Small carcinoma next to a dominant benign lesion
§ Complex proliferative lesion
§ Low grade ductal ca, lobular carcinoma and small cell ductal ca
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INTRAOPERATIVE CONSULTATION
As there was the need to confirm the nature of the tumour (benign or malignant) and to
take therapeutic decisions accordingly,Frozen section technique was developed.
Margin re-excision is the most common indication for reoperation in patients
undergoing BCT.
If Patients undergoing breast conservation therapy for early breast carcinomaare given
adequate margin and RT they may have similar outcomes comparable to patients
undergoing mastectomy.And also inadequate (close) margins have resulted in increased
re-excision rate of20% to 70%  and re-operation has resulted in increased cost of health
care and increased risk of surgery and delay to subsequent radiation and other therapy.
The need for reoperation can be decreased by Intra-operative consultation of sentinel
lymph node (SLN) and lumpectomy specimens  with the pathologist and resecting the
additional breast tissue and/or performing Axillary lymph node dissection during the
initial surgery for breast cancer.
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FROZEN SECTION
Dr. Louis B Wilson has developed the “FROZEN SECTION” in the year 1905, prior to
this, Dr. Thomas S Cullen also was involved in the studies of the same, but only after the
fixation with formalin. Then, Dr William Welch, a pathologist experimented with
Cullen's procedure but without clinical concerns. Therefore, Dr. Wilson was accredited
for pioneering the procedure.
The (5)cryostat is a key instrument used for cryosection, which is principally
a microtome inside a freezer. The microtome is capable of slicing sections as thin as 1
micro metre compared to usual histology slice which is cut at 5 to 10 micrometres. The
specimen isplaced on a metal tissue disc which is again secured in a chuck .It is then
frozen rapidly to about –20 to -30 °C. The specimen is embedded in a gel like medium
called OCT. At this temperature, most tissues become rock-hard. The fat or lipid rich
tissue usually requires a lower temperature. Each tissue has a preferred temperature for
processing.  Using microstat portion of cryostat the specimen is cut frozen,and that
section is picked up on a glass slide and stained with hematoxylin and eosin. The sample
preparation is much more rapid than with traditional histology technique. It takes around
10 minutes compared to 16 hours for histology. However, the quality of the sections is
much lower technically.
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Tissue embedded within OCT, mounted on a chuck in a cryostat and ready for section
production
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ADVANTAGES
§ If more tissue is needed for making an accurate diagnosis, the surgeon is
able to obtain an additional sample, without a second operation.
§ If the lumpectomy specimen is found to be cancerous and requires
mastectomy the mass can be removed at the same time.
§ If the tissue is found to be benign, then it may not require further procedure
and thesurgery can end.
§ It can help to ensure that the tumourmass and its surrounding borders are
removed completely.
§ The surgeon and pathologist are able to collaborate to take care of the
patient.
LIMITATIONS(5)
The main reason why Frozen section is not routinely done at most institutions are:
§ Technical difficulties in freezing tissue.
§ It needs costly equipments
§ It introduces artifacts  due to freezing and
§ there is tissue loss during sectioning
§ By using standard FS techniques freezing or adequate sectioning of
lumpectomy specimens with high adipose tissue isdifficult.
§ The Amount of tissue used in frozen section is limited
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INTRAOPERATIVE IMPRINT SMEAR CYTOLOGY
Imprint cytology (6) is known since 1927. It was first reported by Dudgeon & then
by Patrick who did a pioneer work on imprint cytology in conjunction with
Dudgeon and in 1934 by Barret. But recently it has achieved recognition as an
adjuvant to frozen section for the intra-operative diagnosis.
Suen et al,(7) 1978 observed that for intraoperative diagnosis, intraoperative
cytology (imprint smear, scrape smear, touch preparation) canprovide valuable
information. It gained popularity and provedto be superior over frozen section.
The imprint cytology became the most common method for analysis as it provided
the results rapidly, lacks artefact and was cost effective. It was a benefit for the
centers with underdeveloped infrastructure, lack of facilities and lack of trained
technicians which was required for frozen section.It may even provide accurate
results than frozen section because the entire surface of the resected
tumourspecimen is sampled.
The tumour specimen is excised and the imprint is obtained by pressing it onto a
glass slide and fixing immediately in alcohol.The smear is stained with
haematoxyllin and eosin and it is analysed by pathologist. With experienced
handsthe result is obtained within 2 to 15 minutes.
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               Touch imprint of metastatic ductal carcinoma in a sentinel node
Charles.E.cox(8) and his colleagues first reported evaluation of lumpectomy
margins by touch preparation cytology in 1991. He declared that its accuracy
was97%.
Andrew J.Creager(9) and his colleagues studied in 141 specimens in 137 patients
and concluded that imprint smear is accurate and rapid method for evaluation of
margin status.
Study Year Sensitivity Specificity NPV NPV accuracy
Cox 1991 100 96.6 100 88 97.3
Creager 2002 80 85 40 97 85
Saarela(10) 1997 38 85 100 88 -
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Mori et al in 2006,(11) conducted a study on intraoperative procedures for assessing
sentinel lymph node metastasis in breast cancer. Imprint smear showed sensitivity of 47%
andspecificity of 98% and frozen section showedsensitivity of 88% and specificity 100%.
Kennedy (18)reportedsensitivity of 75 to 100% for imprint cytology and 59% to 91% for
frozen section.
In 2004 Suzanne klimberg(19) evaluated the use of touch preparation in diagnosis and
evaluation of surgical margins and concluded that specificity and sensitivity was
100%.
Valdes EKin 2007,(20)studied the role of Intra-operative touch preparation cytologyin re-
excision lumpectomy specimens and reported the sensitivity of 75%, specificity of
82.8%, positive predictive value of 21.4%, and negative predictivevalue of 98.2%.
Sachins.colte in 2010,(21) studied the Role of scrape cytology in intraoperative diagnosis
of tumor in  75 cases  and  73 could be correctly differentiated into benign and malignant
tumors, with an accuracy rate of 97.3%.
François D'Halluin(22)studied in 400 lumpectomy cases and concluded that touch preps
isreliable and useful method for surgeons in assessing surgical margins in  breast
conservation surgeries in breast cancer .
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The diagnostic accuracy of FNAC was 90.2% and that of imprint 94.1% with no false
negatives. Two imprint smears and one aspirate designated suspicious were proved to be
benign. The combination of FNAC and imprint cytodiagnosis gave a diagnostic accuracy
of 96% thus proving their value in the rapid diagnosis of breast lesions.
Ahamareen,(23) in 2004 assessed and compared  the efficacy of Touch Imprint Cytology
and frozen section in the diagnosis of various pathological processes. He examined 60
cases who came for intraoperative consultation from various sites of the body.He found
that Touch Imprint Cytology alone may provide a correct diagnosis in majority of cases
with less expense compared to frozen section   that requires sophisticated cryostat
machine.
Cherie H.dunphy(24)  in 2011, studied Applications of Touch Preparation Cytology
in Lymph Nodes and Extranodal Tissues for Evaluation of Hematolymphoid
Disorders
Jones L in 2004 (17)concluded that imprint cytology from image guided core biopsy
enables the same day diagnosis..
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Menes TS in2003(25) studied on intraoperative detection of sentinel lymph node
metastases from breast cancer.He reported that  touch preparation allowed  quick
Intraoperative evaluation of the sentinel lymph node metastasis without wasting
significant tissue .
Henry S.Tillmanin 2003,studied in 247 patients for 4 Years and reported that touch prep
was as accurate as frozen section in detecting lymph node metastasis  but it is simple and
rapid.
AIM OF THE
STUDY
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AIM OF THE STUDY
· To evaluate the accuracy of intra-operative imprint smears in breast tumors
· To calculate the sensitivity and specificity of imprint smear in breast tumors
· To correlate imprint smear with histopathological findings
METHODS & MATERIALS
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METHODS AND MATERIALS
Study group : All female patients undergoing elective surgeries for
Breast lump
Study design : Prospective study
Place Of Study : Department of General surgery,
Kilpauk Medical College Hospital
Kilpauk, Chennai – 10.
Duration of study : 6 months
METHODOLOGY :
Inclusion criteria : Female Patients undergoing elective surgeries for breast
Exclusion criteria : Patient with acute breast abscess
62 | P a g e
DATA COLLECTION
· Clearance from ethical committee obtained.
· Thorough clinical history taken and physical examination were done for all
patients.
· Pre-operative investigations done and fitness foranaesthesia and surgery obtained.
· Before surgery, Patient was informed about the procedure and written consent for
surgery obtained. Depending upon the FNAC report, each patient underwent
surgery either excision biopsy, lumpectomy, simple mastectomy or modified
radical mastectomy with or without axillary dissection.
The tumourspecimens before putting into formalin, bisected and macroscopic features
inspected. The cut surface of specimenpressed on to a clean non-greasy glass slide after
mopping the blood and fixed with isopropyl alcohol. And then, stained with eosin and
hematoxyllin. The smears were interpreted by the pathologist.
The imprint smear reports were compared with the final histopathological examination
reports.
The results were analysed statistically for sensitivity, specificity and diagnostic accuracy.
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MATERIALS USED FOR IMPRINT SMEAR
MICROSCOPIC
PICTURES
64 | P a g e
Fig A
Imprint smear of fibroadenoma showing
epithelial and stromal cells
Fig C
Imprint smear of ductal carcinoma showing
pleomorphic and hyperchromatic ductal
epithelial cells
Fig B
hpe of fibroadenoma showing epithelial
and stromal cells
                            Fig D
Hpe of ductal carcinoma showing comedeo
pattern of epithelial cells and neoplastic
cells with hyperchromatic and vesicular
nuclei
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                                                Figure E
Imprint Smear from benign lesion showing uniform arranged
ductal  cells, with normal nucleus to cytoplasm  ratio and fine
chromatins
OBSERVATION
AND
ANALYSIS
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OBSERVATION AND ANALYSIS
A total of 50 patients who underwent surgeries for breast tumoursbetween2014 to 2015 at
our hospital were selected for study as per the inclusion and exclusion criteria.
AGE DISTRIBUTION OF PATIENTS
AGE OF THE
PATIENT BENIGN MALIGNANT TOTAL
11 TO 20 5 0 5
21 TO 30 14 1 15
31 TO 40 7 2 9
41 TO 5O 0 9 9
51 TO 60 3 5 8
61 TO 70 0 4 4
The age incidence ranged from 18 years and 70 years .The benign lesions most
commonly involve the age group between21 to 30 years. The malignant lesions
commonly involve the age group between 41 to 60 years.
11 TO 20
10%
21 TO 30
30%
31 TO 40
18%
41 TO 5O
18%
51 TO 60
16%
61 TO 70
8%
TOTAL AGE DISTRIBUTION OF PATIENTS
11 TO 20 21 TO 30 31 TO 40 41 TO 5O 51 TO 60 61 TO 70
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11 TO 20
17%
21 TO 30
48%
31 TO 40
24%
41 TO 5O
0%
51 TO 60
11%
61 TO 70
0%
BENIGN
11 TO 20 21 TO 30 31 TO 40 41 TO 5O 51 TO 60 61 TO 70
11 TO 20
0%
21 TO 30
5% 31 TO 40
9%
41 TO 5O
43%
51 TO 60
24%
61 TO 70
19%
MALIGNANT
11 TO 20 21 TO 30 31 TO 40 41 TO 5O 51 TO 60 61 TO 70
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PRESENTATION:
All the patients admitted with the complaints of lump in breast.The other common
presentations are pain over the lump/ breast, discharge from the nipple and axillary
lump.The duration varied from few months to years.
DURATION OF SYMPTOMS:
The average duration of symptoms was 5.5 months. The average duration of symptoms
for benign tumour was 3.6 months. The average duration of symptoms for malignant
tumour was 6.9 months.23 patients had lump in right breast and 27 had lump in left
breast.5 patients had lump in both the sides.
Among 50 patients, 2 patients  of multiple fibro adenomas had a family history of
multiple fibromatosis ,one in mother and other in sister , who also underwent surgeries. 3
carcinoma breast patients had history of ca breast – 2 in mother and 1 in elder sister.
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SIZE OF THE TUMOUR:
The size of the tumour varied from 1.5 to 7cm.The size of benign lesions varied from 1.5
to 6cm.The size of malignant lesions varied from 3 to 7cm.
Size of lump BENIGN MALIGNANT
<3cm 11 -
3 TO 6cm 17 16
>6cm 1 5
total 29 22
0
2
4
6
8
10
12
14
16
18
<3 3 TO 6 >6
11
17
1
0
16
5
SIZE OF THE LUMP
BENIGN MALIGNANT
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RESULTS OF IMPRINT SMEAR CYTOLOGY
Intra-operative imprint smears are taken from the tumour specimens and correlated with
histopathological report.
The imprint smear report showed 30 benign and 20 malignant lesions.
Out of 30 cases, only 1 patient who showed benign lesion in intra-operative imprint
smear showed infiltrating ductal carcinoma in histopathological examination, following
which she underwent MRM
DIAGNOSIS NO.OF PATIENTS
BENIGN                             30   (false negative -1)
MALIGNANT 20
TOTAL 50
BENIGN, 29, 58%
MALIGNANT, 21,
42%
HISTOPATHOLOGY REPORT
BENIGN MALIGNANT
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The accuracy rate of the benign tumour is 100%
False positive rate is 0%
          HISTOPATHOLOGY REPORT OF BENIGN LESIONS
HISTOPATHOLOGY REPORT CASES
FIBROADRENOMA 18
FIBROCYSTIC DISEASE 5
LOBULAR HYPERPLASIA 2
BENIGN PHYLLOIDES 3
GRANULAMATOUS MASTITIS 1
TOTAL 29
Out of 20 cases reported as malignant, imprint smear showed 19 cases accurately.
18
5
2 3 1
29
0
4
8
12
16
20
24
28
HISTOPATHOLGY OF BENIGN LESIONS
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False negative reports may be due to 1) interpretative errors:  the morphological changes
of the tumour cells particularly in well differentiated ductal and lobular carcinoma that
remains subtle and 2) insufficient cells: due to the presence of more fibrous stroma
especially in schirrous type of ductal carcinoma , the number of the tumour cells
transferred to the slide is minimal and insufficient.
Accuracy rate of malignant lesion is 95.23%
False negative rate is 4.76 %
Test report malignant benign
positive 20(a)
True positive
0(b)
False positive
negative 1(c)
False negative
30(d)
true negative
True Positive are those patients diagnosed as positive by the test and actually have the
disease.
False Positive are those patients diagnosed as positive by the test and actually do not have
the disease.
False negative are those patients diagnosed as negative by the test and actually have the
disease.
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True Negative are those patients who do not have the disease and diagnosed as negative
by the test.
1) Sensitivity
It is the ability of the test to identify all the patients who have the disease.
Sensitivity =True positive/ (True positive +False negative)
= a / (a + c) * 100
            = 20 / 21 * 100
                  = 95.23%
2) Specificity
It is the ability of the test to identify correctly all those patients who do not have the
disease
Specificity = True negative / (True negative + False positive)
= d / (d + b)* 100
 = 30 / (30 + 0) * 100
  = 100%
3) Positive predictive value ( PPV )
  PPV = True positive / (True positive + False positive)
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= a / (a + b) * 100
 = 20 / 20 * 100
 = 100%
4) Negative predictive value
 NPV= true negative / (true negative + false negative)
   = d / (d + c) * 100
   = 30 /31 * 100
           = 96.77 %
Diagnostic accuracy = True positive + true negative      * 100
                                    True positive +False positive +
                                    True negative +False negative
                                    =   20 + 30        * 100
                                      20 + 0 + 30 + 1
                             = 50/51 *100 = 98.03 %
DISCUSSION
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DISCUSSION
The need for intraoperative diagnostic accuracy of the nature of the tumour has lead to
the development of imprint smear and frozen section techniques .It is an essential part of
the surgeon during the patient’s workup for timely and appropriate surgical intervention.
If the tumour is found to be malignant, the surgeon can do extensive dissection and
lymph node removal in the same sitting without the need for second surgery.
With increasing incidence of breast cancers it is necessary to diagnose the disease rapidly
and accuarately. FNAC, Imprint smear and frozen section are the various methods used
in various combination for diagnosis with their advantages and limitations.
FNAC is an OPD procedure which is simple,rapid, painless, cost-effective and relatively
non-invasive procedure done without any special equipment or preparation .It eliminates
the need for open biopsy procedure. Practically, there is no contraindication to FNAC. It
can be done in pregnant women, children and high risk patients without any major
complication. But it has its own limitations such as inadequate sampling in smaller lesion
and deep seated lesions. Most often diagnosis is ‘suspicious of malignancy ‘,but not
confirmatory. In such conditions, the surgeon encounters a dilemma to advise appropriate
modality of surgery for the patient.
 Frozen section is a standard technique for intraoperative evaluation of the tumour.
However it has many limitations such as need of costly equipment, sampling error in
large specimen, freezing artefacts.
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Imprint smear, scrape smear and touch preparation were described in early 20th century
by Dudgeon and Patrick and it is widely used in evaluating the margins in breast
conservation surgeries and hence gained popularity.
 However all these intraoperative diagnostic methods are not equivalent to the final
histopathological examination, which is a gold standard.
In our series, the precision of intra operative imprint smear in breast tumours has been
evaluated. In accordance to the hypothesis that neoplastic cells adhere to the slide at a
greater degree compared to the fat,this method has been proposed. The sensitivity,
specificity,positive predictive value, and negative predictive value has been calculated .
In 1991, Cox and his colleagues reported the intraoperative evaluation of breast tumour
using touch preparation in the evaluation of margin status. He reported the specificity of
96.6 %  andsensitivity of 100 % in his study of 114 patients undergoing surgeries for
breast tumours.
Saarela in 1997, reported that imprint smear was 85 % accurate in contrast to the other
studies ,who claimed that it was high.
Klimberg in the year 1998 studied in 83 patients and reported 100 % sensitivity,
specificity , PPV and NPV .
Several studies have been conducted to compare the accuracy of imprint smear and
frozen section. Tribe CR suggested that imprint plays the role  inaccurate diagnosis and
can be used in places with lack of trained technicians and equipments. Tomohiko Aihara
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compared frozen and touch imprint cytology and reported that sensitivity of both was
almost equivalent.
 D.S Quill(32) studied in 86 lymph node specimens obtained from 13 patients and
reported sensitivity of 93 %, specificity of 98 % and PPV of 98 % for imprint cytology.
Singh et al (1982 )found accuracy rate of 100 %.Khanna et al(13) reported 98 %
sensitivity and 100 % specificity ,Quershi et al (2007) suggested that imprint cytology is
a reliable and quick method to evaluate intra operatively in appropriate time.
Hiregoudhar et al reported false negative rate of 2.5 %.
Sushma N Ramrej(34) concluded that it is a quick and reliable method ,when taken into
consideration the  clinical presentation and macroscopic appearance of the  tumour
specimen, can provide accurate results.
AleksanderNiziolek , (35) 2013  suggested that intra operative evaluation of sentinel
lymph node  gives the possibility to proceed with lymph node dissection in one –step and
start earlier adjuvant therapy.
In our series, we reported aspecificity of  100 %,sensitivity of 95.23 %,  PPV of 100 %
and NPV of 96.77 % .Only one case reported as benign found to be infiltrating ductal
carcinoma on histopathological examination.21cases were malignant and found to be
infiltrating ductal carcinoma. 29cases were benign  of which 18 werefibroadenomas , 5
fibrocystic disease, 1  granulomatous mastitis , 3phylloides  and  2 werelobular
hyperplasia.
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In order to avoid re-operation, proper preoperative counselling, triple assessment and
intra operative imprint smear is necessary.
As breast conservation surgeries for early breast carcinoma is gaining more importance,
intra- operative imprint smear has become a key tool for assessing the status of the
tumour margins. Re exicision can be perfomed at the same sitting if the margins are
found to be positive, with avoidance of re operation. Many studies has  suggested that the
risk of local recurrence can be reduced by excising adequate margin around the tumour,
giving post-operative adjuvant  radiotherapy  and using tamoxifen for patients with ER
positive tumour.
Intra operative imprint smears are also used in the evaluation of nature of sentinel lymph
node.SLN is the node that receives lymphatic drainage first from the tumour site. If
sentinel lymph node is positive for tumour,axilla   also has to be treated .This is achieved
by dissection of level 1 and 2 axillary lymph nodes.
Many researches are in the progress in studying DNA markers and
immunohistochemistry in imprint cytology smear. Imprint cytology is gaining importance
in also tumours involving cervix, uterus, parotid, thyroid, parathyroid,skin,kidney and
prostate and also lymphoproliferative disorders.
With increasing incidence of cancers, the need for early, rapid diagnosis and treatment
has developed.Due to limitations of FNAC,in situations wherethe results aresuspicious,
open biopsy is done in all centers where there is no facilities for frozen section.
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Intra operative imprint smear do not need specialized equipment. It is very rapid, simple
and economic diagnostic method for intra operative consultation with accuracy rate
similar to frozen section and can be used in the institutions with inadequate surgical
pathological laboratory to give an opinion on the nature of tumor.
CONCLUSION
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CONCLUSION
Intra operative imprint smear aids in the diagnosis of the nature of the tumour on-table
similar to frozen section but at a rapid time using simpler techniques and instruments
with the help of cytopathologist. It is also used in determining the status of the margins in
breast conservation surgeries and the status of sentinel lymph nodes. This helps the
surgeon to take decision on table regarding the surgical procedure to be done without the
need for re operation.
Intraoperative cytology has higher accuracy rates. It preserves the cellular details, and
there is possibility to identify the focal and macroscopically unidentifiable neoplastic
lesion in large tissue fragments.
The disadvantages of intraoperative cytology are very few. With the experience of
pathologists higher accuracy rates can be achieved. Though it is not possible to
distinguish in situ from infiltrating carcinoma and also evaluation of invasion depth, it
can be used as an adjunct for histopathological examination.
In the present study, the specificity was 100 %, sensitivity was 95.23 % and overall
diagnostic accuracy was 98.03 %.
Finally we concluded that imprint cytology is simple, fast, easy, cost effective and
reliable technique for the evaluation of breast tumor intra operatively where the facilities
for frozen section is not available. The sensitivity and specificity supports their utility for
intra operative diagnosis.
SUMMARY
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SUMMARY
To evaluate the accuracy of intra operative imprint smear cytology a study was carried
out in 50 patients admitted in our hospital as per inclusion and exclusion criteria. Imprint
smears were taken intra operatively and were compared with the histopathological
examination.
The results obtained are:
Sensitivity of the test was 95.23 % and specificity was 100 %.
The overall diagnostic accuracy was 98.03 %.
The positive predictive value was 100 % and negative predictive value was 96.77 %.
The accuracy rate for benign lesions was 100 % and for malignant lesions was95.23 %
False positivity 0 %
False negativity 4.76 %
Whenever FNAC reports are inconclusive, intra operative imprint smear aids in the
diagnosis of the nature of the tumour and avoids repeat surgeries .it also helps in making
decisions in breast conservation surgeries in evaluation of tumour margins .It aids in
taking decisions regarding axillary node dissection in the same sitting by assessing the
sentinel lymph node status.Recently immunohistochemistry and DNA markers are also
being evaluated intra operatively in imprint smears.
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PROFORMA
NAME:                                                                           UNIT NO.:
I.P.NO.:
AGE/SEX:
OCCUPATION:                                                            DATE OF ADMISSION:
ADDRESS: DATE OF DISCHARGE:
CONTACT NO:
COMPLAINTS:
   Lump in  breast since     duration
Pain  in  breast since     duration
   Nipple discharge in  breast since   duration
   Nipple retraction in  breast since   duration
HISTORY:
PAST HISTORY:
FAMILY HISTORY:
PERSONAL HISTORY:
MENSTRUAL HISTORY:
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OBSTETRIC HISTORY:
TREATMENT HISTORY(DRUGS):
GENERAL PHYSICAL EXAMINATION:
HT: WT: BMI:
VITALS:
BP: PR: RR:
Breast examination:
INSPECTION:
    Arms by the side of the body
    Arms raised above the head
    Arms pressing the hips
    Bending forward
1.Breast:
    Position
    Size and shape
    Puckering or dimpling
2.Skin over breast:
Colour and texture
    Engorged veins
Peau`d orange
Dimpling,puckering
    Nodules
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Ulceration ,fungation
3.nipple:
     Presence
     Position
     Number
     Size and shape
surface
     Discharge
4.areola:
Colour
    Surface
    Size and Texture
5.arm and thorax:
    Edema
    Nodules
6.axilla and supraclavicular fossa
PALPATION
In sitting position
In semi recumbent position
In recumbent position
· Local temperature and tenderness
· Position of lump
· Number
· Size and shape
· Surface
· margin
· consistency
· fixity to breast tissue
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· fixity to skin
· fixity to fascia and muscles
· palpation of nipple
EXAMINATION OF LYMPH NODES;
Axillary:
· pectoral
· brachial
· subscapular
· central
· apical
Cervical:
supraclavicular
SYSTEMIC EXAMINATION:
CVS:
RS:
P/A: including PV and PR
CLINICAL IMPRESSION:
INVESTIGATIONS:
RENAL PROFILE
Random sugar Urea Creatinine
Complete Hemogram
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TC DC ESR HB Platelet count
ECG all leads
CXR
Fnac
USG breast
Mammogram
USG abdomen
INTRAOPERATIVE IMPRINT REPORT
SURGERY PERFORMED
HISTOPATHOLOGY REPORT
SUMMARY:
CONSENT

MASTER CHART
s.no. IP.NO Name Age
Duration of
symptoms
Lump size
Breast
side
Family history FNAC Procedure
Imprint
smear
HPE Remarks
1 6670 SELVA RANI 50 2m 4 R - S TB+MRM M IDC
2 6798 SAROJA 70 6m 5 L - S TB+MRM M IDC
3 6784 SANGEETHA 15 4m 2 R - B EB B FA
4 7854 AMUDHA 22 10m 3 R - B EB B FA
5 7965 PREETHI 18 6m 2 L - B EB B FCD
6 7976 MANJULA 56 5m 4 L - S TB+MRM M IDC
7 8800 RAJESWARI 20 12m 2.5 R - B EB B FA
8 8865 GOMATHI 40 .5m 4 L - B EB B IDC FALSE NEG
9 8976 ANNALAKSHMI 20 2m 3 B/L - B EB B FA
10 8876 JEEVA 55 1m 6 L - M MRM M IDC
11 8978 MALATHI 30 18m 3+2 B/L PRESENT B EB B FCD
12 9123 FARITHA 42 2m 5 R - S TB+MRM M IDC
13 9345 GOMATHI 30 3m 4 R - B EB B FA
14 9321 SANGEETHA 30 8m 2 L - B EB B FA
15 9356 MATHEENA 38 4m 2.5 L -  B EB B FA
16 9432 FATHIMA 30 1.5m 2 R - B EB B FA
17 9443 MANGALAKSHMI 35 4m 2 R - B EB B GM
18 9449 JAYANTHI 22 3m 2 R - B EB B LH
19 9564 YAMUNA 24 2.5m 3 L - B EB B FCD
20 9568 INDRA 53 14m 5 L PRESENT M MRM M IDC
21 9588 KAMALA 70 1m 6 L - S TB+MRM M IDC
22 9590 JAYALAKSHMI 37 5m 7 L - B EB B PHY-B
23 9780 PALANIYAMMAL 52 2m 4 L - S EB+MRM M IDC
24 9796 INDRA 53 12m 5 L - S TB+MRM M IDC
25 9998 PRIYA 21 3m 4/1.5 B/L - B EB B FCD
26 11123 LAKSHMI 32 2m 2/1.5 B/L - B EB B FA
27 11234 ARPUTHAMARY 48 4m 5.5 L - M MRM M IDC
28 11243 VALLI 40 5m 5 L - B SM B PHY-B
29 12345 MANJULA 28 1.5m 3 R - B EB B FA
30 12324 SEETHA 35 4m 2/2.5 B/L - B EB B FA
31 13465 SASIKALA 22 6m 3.5 L - B EB B FA
32 13654 KUMARI 50 2m 4 R -- M MRM M IDC
33 13876 CHELLAMMA 55 4m 4 R - B EB B FCD
34 13986 RANI 50 2m 6 L - S TB+MRM M IDC
35 13997 BACKIA 44 11m 4 R - S TB+MRM M IDC
36 11465 SAVITHRI 41 3.5m 3 L PRESENT M MRM M IDC
37 14765 BHARATHI 20 10m 3 L - B EB B FA
38 14567 MALINI 35 1m 3 R - B EB B FA
39 14666 SHANTHI 55 4m 3.5 R - B EB B FA
40 14578 MEENA 22 2m 3 L - B EB B FA
41 15676 GAYATHRI 22 1m 3 L - B EB B LH
42 16782 MUTHULAKSHMI 39 1m 2.5 L - B EB B FA
43 17689 MALLIGA 48 .5m 4 L PRESENT S TB+MRM M IDC
44 18432 MANIMEGALAI 33 3.5m 4.5 L - S TB+MRM M IDC
45 18445 SRIDEVI 24 11m 4 R - S TB+MRM M IDC
46 18867 KANNIYAMMAL 66 1.5m 6 R - M MRM M IDC
47 19013 RATHIKA 23 2m 3 R - B EB B FA
48 19024 SUPAMMAL 70 2m 5 L - M MRM M IDC
49 19876 KAMACHI 34 5m 4 L -- B EB B PHY-B
50 19998 BAKKIYA 44 4m 6 L -- S TB+MRM M IDC
MASTER CHART
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KEYS  TO MASTER CHART
B – Benign
M – Malignant
S – Suspicious
EB         –    Excision Biopsy
TB         –    Trucut Biopsy
MRM    –    Modified Radical mastectomy
IDC       –    Infiltrating ductal carcinoma
FA         –    Fibroadenoma
FCD       –    Fibrocystic disease
LH         –    Lobular hyperplasia
GM       –    Granulomatous mastitis
Phy-B   –    Benign Phylloidestumour
B/L       –    Bilateral breast
R           –    Right breast
L           –    Left breast
